Skip to main content
Top
Published in: Rheumatology International 1/2005

01-11-2005 | Original Article

HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus

Authors: Antoni Hrycek, Urszula Siekiera, Paweł Cieślik, Witold Szkróbka

Published in: Rheumatology International | Issue 1/2005

Login to get access

Abstract

Objective

The objective of this study was to evaluate the genetic profiles of selected cytokines (transforming growth factor beta 1, tumor necrosis factor alpha, interleukin-6, interferon gamma, and interleukin-10) in systemic lupus erythematosus and the contributions of human leukocyte antigen (HLA)-DRB1 and -DQB1 alleles to susceptibility for this disease.

Patients and methods

The study was carried out in 24 SLE patients and 36 healthy controls (from Upper Silesia) using polymerase chain reaction methods. All persons were of Caucasoid origin. Standard association analysis was used to compare the HLA alleles and frequency of cytokine gene polymorphisms between these groups.

Results

Only the frequency of HLA-DRB1*07 allele was higher in SLE patients than controls (odds ratio 2.92, 95% confidence interval 1.16–7.33), but the difference did not reach statistical significance when Bonferroni’s adjustment procedure was performed. No other significant associations were noted between class II alleles (DR1-DR6, DR8-DR10, DQ1-DQ4) and SLE. The frequency of the interleukin-6 GG and GC genotypes was significantly higher in SLE patients than in controls, and a significantly higher percentage of the G vs C alleles between patients and controls was revealed (odds ratio 2.53, 95% confidence interval 1.37–4.65, chi-squared test 8.16, P<0.05). The most significant association of increased frequency of the G allele with SLE was more commonly noted in HLA-DRB1*07-positive patients (odds ratio 10.29, 95% confidence interval 5.34–19.83, P<0.001). These data indicate that this combination could contribute toward determining the susceptibility to SLE, but its possible significance will require confirmation by further studies.
Literature
1.
go back to reference Lindqvist AKB, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571CrossRefPubMed Lindqvist AKB, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571CrossRefPubMed
2.
go back to reference Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D (1985) Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52–57PubMed Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D (1985) Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 28:52–57PubMed
3.
go back to reference Tsao BP (2002) An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4:359–367PubMed Tsao BP (2002) An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4:359–367PubMed
4.
go back to reference Tan FK, Arnett FC (1998) The genetics of lupus. Curr Opin Rheumatol 7:399–408 Tan FK, Arnett FC (1998) The genetics of lupus. Curr Opin Rheumatol 7:399–408
5.
go back to reference Tsao BP (1998) Genetic susceptibility to lupus nephritis. Lupus 8:585–590CrossRef Tsao BP (1998) Genetic susceptibility to lupus nephritis. Lupus 8:585–590CrossRef
6.
go back to reference Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397–408CrossRefPubMed Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397–408CrossRefPubMed
7.
go back to reference Davies EJ, Steers G, Ollier WER, Grennan DM, Cooper RG, Hay EM, Hillarby MC (1995) Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheumatol 34:221–225PubMed Davies EJ, Steers G, Ollier WER, Grennan DM, Cooper RG, Hay EM, Hillarby MC (1995) Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheumatol 34:221–225PubMed
8.
go back to reference Sullivan KE (2000) Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 26:229–256PubMed Sullivan KE (2000) Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 26:229–256PubMed
9.
go back to reference Gladman DD, Urowitz MB, Darlington GA (1999) Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 8:466–470CrossRefPubMed Gladman DD, Urowitz MB, Darlington GA (1999) Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 8:466–470CrossRefPubMed
10.
go back to reference Schotte H, Willeke P, Rust S, Assmann G, Domschke W, Gaubitz M, Schluter B (2003) The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed Schotte H, Willeke P, Rust S, Assmann G, Domschke W, Gaubitz M, Schluter B (2003) The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed
11.
go back to reference Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, Schlechte JA (1998) Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci 840:762–772PubMed Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, Schlechte JA (1998) Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann N Y Acad Sci 840:762–772PubMed
12.
go back to reference Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P (2001) Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 10:424–430CrossRefPubMed Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P (2001) Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 10:424–430CrossRefPubMed
13.
go back to reference Wilder RI (1998) Hormones, pregnancy and autoimmune diseases. Ann N Y Acad Sci 840:45–50PubMed Wilder RI (1998) Hormones, pregnancy and autoimmune diseases. Ann N Y Acad Sci 840:45–50PubMed
14.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
15.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed
16.
go back to reference Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235PubMed Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235PubMed
17.
go back to reference Gardner MJ, Altman DG (1989) Statistics with confidence. British Medical Journal Books, London Gardner MJ, Altman DG (1989) Statistics with confidence. British Medical Journal Books, London
18.
go back to reference Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. Wiley and Sons, New York Hochberg Y, Tamhane AC (1987) Multiple comparison procedures. Wiley and Sons, New York
19.
go back to reference Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM (2001) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10:473–479CrossRefPubMed Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM (2001) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10:473–479CrossRefPubMed
20.
go back to reference Schur PH (1995) Genetics of systemic lupus erythematosus. Lupus 4:425–437PubMed Schur PH (1995) Genetics of systemic lupus erythematosus. Lupus 4:425–437PubMed
21.
go back to reference Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNF alpha, p 75 sr TNF alpha, sr IL-2 alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22 Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNF alpha, p 75 sr TNF alpha, sr IL-2 alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22
22.
go back to reference Linker-Israeli M, Deanes RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinkenberg JR ( 1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123PubMed Linker-Israeli M, Deanes RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinkenberg JR ( 1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123PubMed
23.
go back to reference Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza L R (1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110–114 Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza L R (1998) Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 17:110–114
24.
go back to reference Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp. Rheumatol 16:283–288 Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp. Rheumatol 16:283–288
25.
go back to reference Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol 24:2314–2317 Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol 24:2314–2317
26.
go back to reference Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WER ( 2002) IL-6 promoter polymorphism at position-174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 20:179–184 Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Mattey DL, Amoli MM, Thomson W, Ollier WER ( 2002) IL-6 promoter polymorphism at position-174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 20:179–184
27.
go back to reference Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376 Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376
28.
go back to reference Youinou P, Le Corre R (1999) The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus. Lupus 8:87–88CrossRefPubMed Youinou P, Le Corre R (1999) The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus. Lupus 8:87–88CrossRefPubMed
Metadata
Title
HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus
Authors
Antoni Hrycek
Urszula Siekiera
Paweł Cieślik
Witold Szkróbka
Publication date
01-11-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0503-8

Other articles of this Issue 1/2005

Rheumatology International 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.